Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rembert von Strandmann
The Valentines Trial: Results of the First One Week Worldwide Multicentre Enrolment Trial, Evaluating the Real World Usage of the Second Generation DIOR Paclitaxel Drug-Eluting Balloon for In-Stent Restenosis Treatment
EuroIntervention
Medicine
Cardiovascular Medicine
Cardiology
Related publications
Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Stent Optimization Using Adjunctive Balloon Dilatation in the Era of Second-Generation Drug-Eluting Stents
Korean Circulation Journal
Internal Medicine
Cardiovascular Medicine
Cardiology
Angiographic Patterns of Restenosis With 2nd Generation Drug-Eluting Stent
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Drug-Eluting Stent Restenosis Rates?
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for In-Stent Restenosis Related Acute Myocardial Infarction: A Retrospective Study
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Network Meta-Analysis of Balloon Angioplasty, Nondrug Metal Stent, Drug-Eluting Balloon, and Drug-Eluting Stent for Treatment of Infrapopliteal Artery Occlusive Disease
Diagnostic and Interventional Radiology
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
Is the Sirolimus Encapsulated Balloon a Reliable Tool for Treating the In-Stent Restenosis?—insights From the SABRE Trial
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Clinical Outcome Following Second-Generation Drug-Eluting Stent Use for Off-Label Versus On-Label Indications: Insights From the Two-Year Outcome of the TWENTE Trial
EuroIntervention
Medicine
Cardiovascular Medicine
Cardiology